To view any of the articles listed hereunder, click on the article of your choice.
| 25 years of permanent prostate brachytherapy, how to proceed |
| A Case of Strand Migration After Prostate Seed Implant |
| A Multi-Institutional, Phase I/II Trial of Dose-per-fraction Escalation for Prostate Cancer |
| A New Simulation Technique Using Virtual Reality Visualization to Optomize Beam Geometry in Prostate Cancer IMRT |
| A Randomized Cross-Over Study Comparing Two Immobilization Devices For The Treatment Of Prostate Cancer Patients Using Megavoltage CT Scanning To Evaluate Setup Accuracy |
| Accelerated Hypofractionated Radiation Therapy with Neoadjuvant and Concomitant Hormone Therapy for Intermediate Risk Prostate Cancer |
| Accuracy of Automatic Prostate Tracking for Online MRIGRT |
| Accuracy of prostate localization using implanted gold markers and Varian´s On-Board Imager system |
| Achieving a Consensus Definition for Anatomic Boundaries of the CTV (Prostate Bed): Methods and Observer Reproducibility using MRI |
| Adenoviral E2F1 And Antisense MDM2 Sensitize Prostate Cancer Cells To Androgen Deprivation and Radiation |
| Adjuvant versus neo-adjuvant hormonal treatment and radical radiotherapy in early stage and locally advanced prostate cancer |
| African-American Patients with Intermediate-Risk Prostate Cancer Have Improved Biochemical Relapse-Free Survival in a Racially Diverse University Population |
| Antisense MDM2 Oligonucleotides Sensitize Androgen-Insensitive Human Prostate Cancer Cells To Androgen Deprivation In Vitro And In Vivo |
| Antisense MDM2 Sensitizes Prostate Tumors to Radiation Therapy and Androgen Deprivation in vivo |
| Bcl-2 and Bax Predict Prostate Cancer Outcome In Men Treated With Androgen Deprivation And Radiotherapy On RTOG 92-02 |
| Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder |
| CAD-Application in Prostate Cancer – is there an clinical use in defintion of GTV for Dose painting |
| Characterization of Real Time Motion of the Prostate Gland in Patients Receiving External Radiotherapy for Localization Prostate Cancer: Tracking During 1157 Fractions with the Calypso System |
| Clinical feasibility of a new robotic needle insertion method to minimize prostate motion during image guided prostate interventions |
| Clinical Impact of a 3 mm versus 5 mm Action Threshold for Correction of Intrafractional Prostate Motion Identified with Electromagnetic Tracking |
| Clinical Outcomes And Late Toxicities After High Dose Rate Brachytherapy Combined With Hypofractionated External Beam Radiation Therapy For Intermediate-high Risk Prostate Cancer |
| Comparison of a pre planned dose distribution with a real time dose distribution in ultra sound guided 3D conformal brachytherapy of prostate cancer |
| Comparison of prostate targeting for Image Guided Radiation Therapy (IGRT) treatment using a conventional CT interface and SYNGO fusion software |
| Comparison of Radiation Proctitis of Prostate Cancer Treated by 3-Dimensional Conformal Radiotherapy (3D-CRT) Alone and 3D-CRT Plus High Dose Rate Implant |
| Comprehensive I-125 multi-seed analysis comparison for prostate brachytherapy – Dosimetry and visibility analysis |
| Correlation of Planning Scan Anatomy and PSA Relapse in Prone Prostate Cancer Patients |
| Cox-2 Overexpression Predicts Prostate Cancer Outcome: An analysis of RTOG 92-02 |
| Daily Image Guided Radiation Therapy for Prostate Cancer: An assessment of treatment plan reproducibility |
| Development of a nomogram to predict grade 2-3 acute GI toxicity (RTOG EORTC) for prostate cancer 3DCRT |
| Difference in rectal wall dose mapping and reduced late rectal mucosal changes at endoscopic evaluation after radiotherapy with daily endorectal balloon for localised prostate cancer |
| Do Prostate Displacements Between 1.5 and 4.4 mm Need Correction? A Randomized Study |
| Dose escalation in prostate cancer with IMRT (76 Gy- 80 Gy) Acute and late toxicity |
| Dose volume constraints and volume effects for rectal toxicity after external RT for prostate cancer |
| Dosimetric Comparison of IMRT Prostate Cancer Treatment with or without On-line Rotation Correction |
| Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer |
| Endorectal Balloons In Prostate Radiotherapy: Difference In Rectal Wall Dose Maps And Reduction Of Late Rectal Mucosa Effects Observed In Rectoscopy |
| Enhanced quality of HDR- interstitial prostate implants due to online-planning procedure |
| Evidence Based Radiation Oncology: Prostate Cancer |
| Expanded Risk Groups Help Determine Which Prostate Radiotherapy Sub-Group May Benefit From Adjuvant Androgen Deprivation Therapy |
| External beam radiotherapy after IOERT for prostate cancer |
| Extracapsular Radiation Dose Annulus Correlates With Biochemical Control in Low-Risk Prostate Brachytherapy Patients: Results of a Prospective Randomized Trial |
| FIRST, the first choice in the management of localised prostate cancer? |
| Greater Than 6 Months of Androgen Deprivation Therapy Does Not Improve Overall Survival for High-risk Prostate Cancer Patients Treated with Radiotherapy or Prostatectomy |
| High Dose Rate (HDR) Monotherapy is Equivalent to Combined HDR Brachytherapy and External Beam Radiation Therapy (EBRT) for Early Prostate Cancer |
| Hypofractionated Stereotactic Radiotherapy for Prostate Cancer: Early Results |
| I-Beam ultrasonography for IMRT treatment of localized prostate carcinoma precision and organ motion |
| Image-Guided Intensity-Modulated Radiation Therapy (IG-IMRT) With Helical Tomotherapy for Prostate Cancer – Importance of Patient Registration For Alignment |
| Image-Guided Radiation Therapy Using an in-room CT – Review of 1762 prostate CT scans |
| Impact of differences in organ contouring and seed localisation by imaging modality on post-implant dosimetry parameters for permanent prostate implants |
| Impact of random position variations on complex dose distributions for prostate IMRT using different margins |
| Impact of rectal preparation with polyethylene glycol (PEG) laxative on pelvic organs geometrical reproducibility |
| Implementation of FEM simulation techniques for organ motion modeling in prostate cancer radiotherapy |
| Implementation of Magnetic Resonance Spectroscopy (MRS) of the prostate into radiotherapy treatment planning |
| Importance of the CT MRI fusion method as a learning tool for CT-based post implant dosimetry in prostate brachytherapy |
| Improvement of Disease Control with Seminal Vesicles Irradiation in Intermediate and High-Risk Patients with Prostate Cancer |
| Improving the Therapeutic Ratio of Prostate Brachytherapy: Dose Escalation in I-125 Prostate Implants |
| IMRT, what have we learned? A systematic review in prostate cancer |
| Influence Of Patient Selection On Outcome In Prostate Cancer Brachytherapy. The Experience Of The Paris Institut Curie/ Hopital Cochin / Hopital Necker Group On 809 Patients |
| Intensity-modulated radiotherapy (IMRT) as primary therapy for prostate cancer – experience of Ghent University Hospital (GUH) |
| Intra- and interfractional movements of the BeamCath urethral catheter for image-guided radiotherapy of prostate cancer |
| Intra-operative Prostate Brachytherapy – Can EUD assist D90 in assessing intra-operative implant dosimetry and quality |
| Inverse Planning in Prostate Cancer |
| Is D90 A Radiobiologically Sound Endpoint for Evaluation Permanent Seed Prostate Brachytherapy? |
| Late genito-urinary morbidity after 3D conformal radiotherapy for prostate cancer – absence of dose and dose-volume effect |
| Late rectal toxicity after prostate cancer 3DCRT: preliminary results from a prospective multi-centric study (AIROPROS 01-02) |
| Late RTOG-EORTC LENT SOMA and CTCAE graded rectal toxicity in relation to dose distributions in the rectum during radiotherapy for prostate cancer |
| Long term outcomes following Iodine-125 monotherapy for localized prostate cancer |
| Long Term Outcomes Following Iodine-125 Monotherapy For Localized Prostate Cancer: The Results Of A Large European Series |
| Long-term Rectal Function Following Permanent Prostate Brachytherapy |
| Long-time results with a median follow up of 80 months in 3-D conformal radiotherapy of localized prostate cancer at moderate dose |
| Margins for prostate treatment using online position verification, focussing on the magnitude of prostate rotation |
| Matched Pair Analysis Of Patients With Prostate Cancer Treated With IMRT Or 3-D Conformal Radiotherapy |
| Molecular Image Validation utilizing the Correlation of Histopathology and Marker Placement System (CHAMPSSM) Protocol |
| Nadir PSA and time to nadir PSA after radiotherapy with and without androgen deprivation as a predictor of prostate cancer outcome |
| Objective verification of the position of the prostate using implanted markers compared to the use of untrasound repositioning systems |
| On-Line Correction in Prostate Radiotherapy Using the AcculocTM Fiducial Localization System-Is this the Gold Standard in Image Guidance Technology |
| Optimising radiotherapy for seminoma using fields based on surgical templates for retroperitoneal lymph node dissection |
| Optimizing Beam Angles in IMRT – A Comparison Study between Class-solution and Optimized Beam Directions in Prostate Cases |
| Partial Volume Analysis In LDR Brachytherapy Of Prostate Cancer- Comparision Of Intraoperative Ultrasound Planning And Postimplant CT Dosimetry |
| Planning challenges for prostate cancer in the IMRT IGRT era |
| Prediction of the bladder wall location in presence of a varying urinary inflow |
| Predictors for rectal and intestinal acute toxicities from 3DCRT prostate cancer |
| Preoperative PSA Velocity Predicts for Relapse after Prostatectomy Only for Non-Obese (Low BMI) Patients |
| Pretreatment PSA Velocity as a Predictor of Disease Outcome Following Radical Radiation Therapy |
| Prostate Brachytherapy combined with androgen deprivation, is there a rationale |
| Prostate Cancer Distribution in Patients Diagnosed by Transperineal Template-guided Saturation Biopsy |
| Prostate Rotation Measured by Electromagnetic Tracking System: A Multi-Center Analysis |
| Prostate Tumor Biomarker Stability In Archival Tissue From Men Treated With Radiotherapy: An Analysis Of RTOG 92-02 And Fox Chase Randomized Trials |
| Pulse-Dose-Rate (PDR) Brachytherapy as Monotherapy for Localized Prostate Cancer |
| Radiation therapy for localized hormone refractory prostate cancer: Results of Patterns Care Study in Japan |
| Reduction of Prostate Movements During radiotherapy – Results of a randomised study |
| Reimplantation for suboptimal prostate implant. Feasibility study |
| Relapse-Free Survival with Escalating External Beam Radiation Doses in the Treatment of Localized Prostate Cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and Hypofractionated 70 Gy at 2.5 Gy per Fraction |
| Relationship between DVH and rectal acute symptoms during high-dose prostate cancer 3DCRT |
| Second Malignancies After Prostate Brachytherapy: Incidence Of Bladder And Colorectal Cancers In Patients With 15 Years Of Potential Follow-up |
| Serial Ultrasound-Determined Post-Void Residual Urine Volumes During External Beam Radiation Therapy for Clinically Localized Prostate Cancer |
| Should PNI Be Included For Risk-stratification Of Prostate Cancer? |
| Side-effects and efficacy of conformal radiation therapy (CRT) in patients with prostate cancer |
| Socio-demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-analysis |
| Stability of Intraprostatic Electromagnetic Transponders in Patients Receiving Radiation Therapy, With and Without Neoadjuvant and/or Concurrent Androgen Suppression Therapy |
| Statin Use Prior to Radiation Therapy for Prostate Cancer Does Not Improve Outcome: The Fox Chase Experience |
| Step & shoot IMRT for the prostate, more beams, less QA |
| Stereographic targeting in prostate IGRT- speed and precision by daily, automatic positioning correction |
| The Benefit of Intraoperative Image-Guided Adaptative Prostate Brachytherapy : the Hôtel-Dieu of Quebec experience |
| The biological significance of longitudinal changes in PSA – Doubling time during biochemical failure |
| The biological significance of longitudinal changes in PSA; post treatment variations and mistaken biochemical failure |
| The clinical evaluation of inter-fraction time trends in prostate positioning during intensity-modulated radiotherapy |
| The clinical rationale and basis for IGRT in prostate radiotherapy |
| The Effect of Obesity on PSA Recurrence Following External Beam Radiation Therapy for Localized Prostate Cancer |
| The Impact of Body Mass Index on Cause-Specific Biochemical and Overall Survival Following Permanent Prostate Brachytherapy |
| The Impact of Primary Gleason Pattern on Survival Following Brachytherapy for Gleason Score 7 Prostate Cancer |
| The impact of set-up error on quality control of a multi-centric study on rectal toxicity during 3DCRT of prostate cancer AIROPROS01-02 |
| The Influence of a Diet on Prostate Movement and Automatic Prostate Localization on Cone-Beam CT scans for Image Guided Radiotherapy |
| The Influence Of Androgen Suppression Therapy For Prostate Cancer On The Frequency And Timing Of A Fatal Myocardial Infarction |
| The Nadir+2 Definition of Biochemical Failure Predicts for Overall Survival |
| The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significant: A Multi-Institutional Pooled Analysis of More Than 7500 Patients |
| The radiobiology of prostate cancer : new thinking from clinical studies |
| The Significance of Organ Motion for Planning Margins in Prostate Radiation Therapy |
| The value of online MRIgRT for prostate deformation |
| Tolerance, Stability and Reliability of Implanted Electromagnetic Transponders in the Prostate: A Multi-Center Analysis |
| Transperineal I-125 Implants for prostate cancer |
| Treatment of intermediate or high risk prostate cancer by dose escalation with HDR brachytherapy: early toxicity and biochemical outcome of two treatment regims |
| Treatment of Prostate Cancer with Photon IMRT and Proton Therapy: a Treatment Planning Comparison |
| Urinary and Bowel Toxicity After External Beam Radiotherapy for Localized Prostate Cancer: Correlation of Acute Versus Late Toxicities |
| Use of dose volume parameters in brachytherapy for prostate and gynaecology |
